🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
IL-22 is an IL-10 family cytokine that plays major actions to increase inte...
Status
Completed
Location
CHU de Nantes
Start Date
2014-08
Trial ID
NCT02847052
Treatments Being Tested
This study aims to investigate the safety and efficacy of the IL-22BP in pa...
Status
Completed
Location
Department of Radiation Oncology
Start Date
2025-06-29
Trial ID
NCT07040943
Treatments Being Tested
This is a phase I, open-label, single-arm, single-center, dose-escalation s...
Status
Not Yet Recruiting
Location
West China Hospital
Start Date
2026-04-28
Trial ID
NCT07562815
Treatments Being Tested
The goal of this phase 1 clinical trial is to evaluate the safety, tolerabi...
Status
Recruiting
Location
West China Hospital of Sichuan University
Start Date
2026-07-13
Trial ID
NCT07583654
Treatments Being Tested
This study aims to investigate the safety and efficacy of the IL-22BP/LNP c...
Status
Recruiting
Location
West China Hospital of Sichuan University
Start Date
2025-01-20
Trial ID
NCT07100210
Treatments Being Tested
Interleukin 22 (IL-22) is known to be regulated by IL-22 binding protein (I...
Status
Completed
Location
Nantes University Hospital
Start Date
2020-12-02
Trial ID
NCT04310189
Treatments Being Tested